Status:

RECRUITING

Prebiotics (Dried Plum) and Immune Function in Postmenopausal Women

Lead Sponsor:

Indiana University

Collaborating Sponsors:

Indiana University School of Medicine

Purdue University

Conditions:

T Cell Response to Dried Plum

Vitamin D Influence on Immune Response

Eligibility:

FEMALE

60-75 years

Phase:

NA

Brief Summary

Prior studies have shown that dietary supplementation with dried plums (also known as prunes) reduces bone loss in postmenopausal women. The purpose of this clinical trial is to understand how dried p...

Detailed Description

Each year in the U.S., an estimated 2 million women (\~6,000 women each day) reach the critical stage of female reproductive aging known as menopause. Menopause is characterized by the permanent cessa...

Eligibility Criteria

Inclusion

  • women 60-75 years of age at the start of the study;
  • 12 or more consecutive months without a menstrual period;
  • willing to include dried plums in their daily diet and collect fecal samples at four time points;
  • ambulatory without assistance;
  • capacity to give informed consent.

Exclusion

  • women who have been on medications known to alter bone or calcium metabolism (e.g., oral bisphosphonates, raloxifene, denosumab, intermittent parathyroid hormone, growth hormone) within 12 months of starting the study. Prior use of intravenous bisphosphonates at any time.
  • women who have been on hormone replacement therapy, steroids (i.e., glucocorticoids), biologics, or chronic NSAID within 3 months of starting the study.
  • women with a previous diagnosis of osteoporosis (i.e., BMD T-score or history of vertebral fracture or fragility fractures of hip, wrist, humerus after the age of 50 yr) or other metabolic bone disease (e.g., osteomalacia or osteogenesis imperfect), renal disease, stroke, heart attack, type 2 diabetes, liver disease or autoimmune diseases (e.g., rheumatoid arthritis, systemic Lupus erythematosus, type 1 diabetes mellitus, IBD) that could affect bone metabolism or T cell biology will be excluded.
  • women who have undergone treatment for cancer within 12 months of starting the study
  • women who have been taking prebiotic or probiotic supplements or natural products that have estrogen-like effects in the past 3 months
  • women who smoke, have a BMI \>40 kg/m2 or \<18.5 kg/m2, or consume \>2 alcoholic drinks per day
  • women who regularly consume dried plums or prune juice (\>1 serving weekly).

Key Trial Info

Start Date :

September 2 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2028

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT07222111

Start Date

September 2 2025

End Date

August 30 2028

Last Update

October 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IU Health University Hospital Clinical Research Center

Indianapolis, Indiana, United States, 46202